KYMR
#931
Kymera Therapeutics, Inc. - Common Stock
112.4 0 USD
+0.03%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+2.84%
Variación mensual
-3.10%
Variación en los últimos 6 meses
+32.10%
Cambio anual
+90.19%
Cierres anteriores
109.3 0
Open
109.5 4
Mínimo
107.4 6
Máximo
115.8 2
Financials
- Market Capitalization 9.35 B
- Employee 273
- Founded 2015
- CEO N/A
- Website www.kymeratx.com
- Headquarter Delaware, United States
- FIGI BBG00SDHC8D1
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-21.09
Relación precio/flujo de caja
167.66
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 890 |  KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 79.78 USD | +1.31% | +5.02% | +2.43% | +101.24% | 10.15 B USD | ||
| 907 |  KRYS Krystal Biotech, Inc. - Common Stock | 331.61 USD | +1.32% | +2.42% | -5.46% | +77.21% | 9.82 B USD | ||
| 933 |  PTGX Protagonist Therapeutics, Inc. - Common Stock | 143.73 USD | +2.73% | +2.04% | -4.13% | +91.31% | 9.30 B USD | ||
| 961 |  ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock | 62.75 USD | +3.31% | -3.10% | -24.13% | +60.49% | 8.86 B USD |